Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Lung Neoplasms 16Carcinoma, Non-Small-Cell Lung 8Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Head and Neck Neoplasms 4Breast Neoplasms 4Sarcoma 3Rectal Neoplasms 3Oropharyngeal Neoplasms 3Carcinoma, Hepatocellular 3Melanoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Tobacco Use Disorder 1Thrombosis 1Stroke 1Solid Tumor, Adult 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Pulmonary Disease, Chronic Obstructive 1Precancerous Conditions 1Pathologic Complete Response 1Osteoporosis 1Nevus, Pigmented 1Neurofibrosarcoma 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Early Intervention, Educational 13Oxaliplatin 12Radiotherapy 11Fluorouracil 10Exercise 10Counseling 10Methods 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Drug Therapy 7Magnetic Resonance Spectroscopy 6Laparoscopy 6Capecitabine 6Surveys and Questionnaires 5Standard of Care 5Proctectomy 5Preoperative Exercise 5Leucovorin 5Psychiatric Rehabilitation 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Blood Specimen Collection 4Biopsy 4Bevacizumab 4X-Rays 3Transanal Endoscopic Surgery 3Robotic Surgical Procedures 3Mastectomy, Segmental 3Irinotecan 3Ileostomy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Rectal Neoplasms × X-Rays × Clear all
NCT06424522 2026-04-21

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
80 enrolled
Gastrointestinal

Low Anterior Resection Syndrome, Rectal Neoplasms

NCT02233374 2022-10-28

PRISM

Royal North Shore Hospital

Phase NA Completed
27 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT03265418 2019-09-04

BioXmark, Rectal Feasibility Trial

Maastricht Radiation Oncology

Phase NA Completed
20 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡